Immunosuppressive therapy in inflammatory ocular surface disease post Steven Johnson syndrome
2011

Immunosuppressive Therapy for Ocular Issues After Stevens-Johnson Syndrome

Sample size: 7 publication Evidence: low

Author Information

Author(s): Balkrishnan C, Sharma Vishnu, Vyas Anupama

Primary Institution: P D Hinduja National Hospital and MRC, Mumbai, India

Hypothesis

Can systemic immunosuppressive therapy improve chronic ocular surface problems in patients recovering from Stevens-Johnson syndrome?

Conclusion

Systemic immunosuppressive therapy may be beneficial for patients with chronic ocular surface problems after Stevens-Johnson syndrome, especially when local treatments fail.

Supporting Evidence

  • Chronic ocular surface complications can occur after Stevens-Johnson syndrome.
  • Local treatments failed in all patients before systemic therapy was considered.
  • The response to systemic therapy was variable among patients.

Takeaway

Some people who get a serious skin condition called Stevens-Johnson syndrome can have ongoing eye problems. Doctors tried giving them special medicine to help their eyes feel better.

Methodology

This was a retrospective observational study involving seven patients treated with systemic immunosuppressive therapy for ocular complications after Stevens-Johnson syndrome.

Limitations

The study is retrospective and did not use objective improvement criteria.

Participant Demographics

Patients included three females and four males, with ages ranging from 18 to 45 years.

Digital Object Identifier (DOI)

10.4103/0301-4738.73701

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication